Pentraxin 3 as a Novel Marker Predicting Congestive Heart Failure in Subjects With Acute Coronary Syndrome

BACKGROUND AND OBJECTIVES: Pentraxin 3 (PTX3) was shown to be elevated in the acute phase of acute myocardial infarction (AMI) and to have prognostic significance in AMI patients. The aim of this study was to estimate whether the value of PTX3 could be used as a prognostic biomarker, with the global...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Dong-Hyeon, Jeon, Hui-Kyung, You, Ji-Han, Park, Mi-Yeon, Lee, Seung-Jae, Kim, Sung-Sik, Shim, Byung-Joo, Choi, Yun-Seok, Shin, Woo-Seung, Lee, Jong-Min, Park, Chul-Soo, Youn, Ho-Joong, Chung, Wook-Sung, Kim, Jae-Hyung
Formato: Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933461/
https://www.ncbi.nlm.nih.gov/pubmed/20830250
http://dx.doi.org/10.4070/kcj.2010.40.8.370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933461/
https://www.ncbi.nlm.nih.gov/pubmed/20830250
http://dx.doi.org/10.4070/kcj.2010.40.8.370

Ejemplares similares